News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Dr. Richard Ho Joins Rosa & Co’s PhysioPD Modeling and Simulation Team
December 19, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Rosa & Co, a leader in drug development modeling and simulation, today announced that Richard Ho, MD-PhD, has joined Rosa as a Principal.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Earnings
Lilly’s guidance has jumped by $10B as GLP-1 sales keep blowing past expectations
October 29, 2026
·
3 min read
·
Annalee Armstrong
Earnings
Merck looks ahead to ‘another year of investment’ as Keytruda cliff looms
October 29, 2026
·
4 min read
·
Heather McKenzie
Earnings
BMS drops Prothena-partnered neuro drug, sales outlook improves on a Q3 beat
October 29, 2026
·
4 min read
·
Gabrielle Masson
Layoff Tracker
LENZ cuts 75% of staff as third quarter earnings disappoint
October 29, 2026
·
111 min read
·
BioSpace Editorial Staff
